Difference between revisions of "Xavier Duportet"
(WEF/YGL stub) |
(WEF/YGL) |
||
| Line 1: | Line 1: | ||
{{person | {{person | ||
| − | |wikipedia= | + | |wikipedia=https://fr.wikipedia.org/wiki/Xavier_Duportet |
| − | |twitter= | + | |twitter=https://twitter.com/duportet |
| − | |constitutes= | + | |linkedin=https://www.linkedin.com/in/duportet |
| − | |image= | + | |constitutes=scientist |
| + | |image=Xavier Duportet.jpg | ||
|interests= | |interests= | ||
| − | |nationality= | + | |nationality=French |
| − | |birth_date= | + | |birth_date=7 December 1987 |
|birth_place= | |birth_place= | ||
|death_date= | |death_date= | ||
|death_place= | |death_place= | ||
| − | |description= | + | |description=Genome architect and founder of Eligo Biotech |
|parents= | |parents= | ||
|spouses= | |spouses= | ||
|children= | |children= | ||
|relatives= | |relatives= | ||
| − | |alma_mater= | + | |alma_mater=INRIA,AgroParisTech, Ohio State University,University of Auckland,Institut Pasteur |
|political_parties= | |political_parties= | ||
| − | |employment | + | |employment= |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
}} | }} | ||
| − | + | '''Xavier Duportet''' is a genome architect and founder of Eligo Biotech<ref>https://www.weforum.org/people/xavier-duportet</ref> | |
| − | '''Xavier Duportet''' is a genome architect<ref>https://www.weforum.org/people/xavier-duportet</ref> | + | |
| + | He was selected a [[WEF/Young Global Leaders 2015|Young Global Leader]] by the [[World Economic Forum]] in 2018. | ||
| + | ==Eligo Bioscience == | ||
| + | Eligo is a [[MIT]]-[[Rockefeller University]] spinoff, backed by top-tier investors Khosla Ventures and Seventure Partners. Eligo Bioscience is bringing precision [[gene editing]] to the microbiome. By combining unique expertise and pioneering IP in [[CRISPR]], [[phage]] engineering and [[synthetic biology]], Eligo is advancing to the clinic highly differentiated therapeutic modalities that can reprogram the microbiome in-situ.<ref>https://www.linkedin.com/in/duportet</ref>. Eligo Bioscience was elected as one of the 30 most innovative companies in the world by the [[World Economic Forum]] in 2017.<ref>https://archive.wikiwix.com/cache/?url=http%3A%2F%2Fwidgets.weforum.org%2Ftechpioneers-2017%2F</ref> | ||
| + | ==Hello Tomorrow]== | ||
| + | Duportet is also the founder and president of [[Hello Tomorrow]], a global [[non-profit]] organization, operating in 45 countries, which goal is to accelerate the development of [[deeptech]] startups that transform disruptive scientific technologies into products or services to solve societal and industrial challenges. Every year, the organisation receives more than 5000 startup applications, gathers more than 1000 deeptech founders via more than 100 events with leaders such as [[Michael Bloomberg]], [[Emmanuel Macron]] and many others, and distributes more than $1M in prizes to the most promising early-stage science startups.<ref>https://www.weforum.org/people/xavier-duportet</ref> | ||
{{SMWDocs}} | {{SMWDocs}} | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
| − | |||
| Line 40: | Line 38: | ||
|site=Wikipedia | |site=Wikipedia | ||
|date=01.01.2022 | |date=01.01.2022 | ||
| − | |url= | + | |url=https://fr.wikipedia.org/wiki/Xavier_Duportet |
}} | }} | ||
Revision as of 02:48, 4 February 2022
 Xavier Duportet      (scientist) | |
|---|---|
 | |
| Born | 7 December 1987 |
| Nationality | French |
| Alma mater | INRIA, AgroParisTech, Ohio State University, University of Auckland, Institut Pasteur |
| Member of | Friends of Europe/Young European Leaders/2017, WEF/Young Global Leaders/2018 |
Genome architect and founder of Eligo Biotech | |
Xavier Duportet is a genome architect and founder of Eligo Biotech[1]
He was selected a Young Global Leader by the World Economic Forum in 2018.
Eligo Bioscience
Eligo is a MIT-Rockefeller University spinoff, backed by top-tier investors Khosla Ventures and Seventure Partners. Eligo Bioscience is bringing precision gene editing to the microbiome. By combining unique expertise and pioneering IP in CRISPR, phage engineering and synthetic biology, Eligo is advancing to the clinic highly differentiated therapeutic modalities that can reprogram the microbiome in-situ.[2]. Eligo Bioscience was elected as one of the 30 most innovative companies in the world by the World Economic Forum in 2017.[3]
Hello Tomorrow]
Duportet is also the founder and president of Hello Tomorrow, a global non-profit organization, operating in 45 countries, which goal is to accelerate the development of deeptech startups that transform disruptive scientific technologies into products or services to solve societal and industrial challenges. Every year, the organisation receives more than 5000 startup applications, gathers more than 1000 deeptech founders via more than 100 events with leaders such as Michael Bloomberg, Emmanuel Macron and many others, and distributes more than $1M in prizes to the most promising early-stage science startups.[4]
References
This page imported content from Wikipedia on 01.01.2022.Wikipedia is not affiliated with Wikispooks. Original page source here
